- 카지노 양상수 CFO Eva Huang Presents Mid- to Long-Term Growth Strategy at APAC Track
- Plans to Expand Presence to Over 80 Countries for Toxins, 70 for Fillers, and 10 for Cosmetics
[by Yoo, Ha Eun] 카지노 양상수, a global total medical aesthetics company, announced its key achievements from last year and outlined its three-year mid- to long-term goals and growth strategies through 2028 at the 2025 J.P. Morgan Healthcare Conference in San Francisco, USA on January 17.
During the Asia-Pacific (APAC) Track session on January 16, 카지노 양상수 revealed its vision of becoming a top global company. The company set future goals to expand its presence to over 80 countries for botulinum toxins, 70 countries for hyaluronic acid (HA) fillers, and 10 countries for cosmetics by 2028.
The outlined 카지노 양상수 include maintaining market leadership in South Korea, accelerating entry into emerging markets such as the Middle East and North Africa, strengthening profitability, and diversifying its portfolio.
카지노 양상수 also presented region-specific strategies. In the U.S., where its botulinum toxin is set to launch officially in the first half of the year, the company plans to target Millennials and Gen Z customers by leveraging skin clinic channels. It aims to meet local medical practitioners' needs with academic content and competitive pricing, targeting a 10% market share in the U.S. aesthetics toxin market within three years of launch. In Europe and China, 카지노 양상수 aims to achieve a 20~25% market share in each region by 2027.
Eva Huang, CFO of 카지노 양상수, emphasized during the presentation, "카지노 양상수 will continue to drive growth globally by leveraging its leadership in the South Korean market, balanced portfolio of toxins, fillers, and cosmetics, and its unique value proposition. We are confident in our ability to become a global leader in the medical aesthetics industry."